Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|November 15, 2018
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification systemPanagiotis T Diamantopoulos, Ioannis Kotsianidis, Argiris Symeonidis, et al.
Cancers|October 16, 2025
Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature OverviewMaria Dimou, Rodanthi Fioretzaki, Calliope Zerzi, et al.
Medicina (Kaunas, Lithuania)|May 25, 2024
A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in GreeceAndroniki Kapousouzi, Fani Kalala, Styliani Sarrou, et al.
Scientific Reports|October 26, 2022
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndromePanagiotis T Diamantopoulos, Emmanouil Charakopoulos, Argiris Symeonidis, et al.
American Journal of Hematology|December 24, 2019
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 studyMartin Dreyling, Armando Santoro, Luigina Mollica, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 30, 2019
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine RegistryPanagiotis T Diamantopoulos, Vasiliki Pappa, Argiris Symeonidis, et al.
Hematological Oncology|October 31, 2022
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab eraTheodoros P Vassilakopoulos, Fotios Panitsas, Zois Mellios, et al.
Therapeutic Advances in Hematology|December 21, 2020
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromesSotirios G Papageorgiou, Ioannis Kotsianidis, Anthi Bouchla, et al.
British Journal of Haematology|August 31, 2020
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomesPanagiotis T Diamantopoulos, Argiris Symeonidis, Vasiliki Pappa, et al.
Hematological Oncology|May 22, 2012
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without RituximabSotirios G Papageorgiou, Panayiotis Diamantopoulos, Georgia Levidou, et al.
Pageof 11